Invest Qatar strengthens engagement with US investors through high-level roadshow

Doha, Qatar: Invest Qatar's Investment Promotion Agency recently concluded a high-level roadshow in New York and Boston, aiming to strengthen ties with leading US investors and businesses. The event showcased Qatar's expanding investment opportunities in technology, biotechnology, life sciences, and healthcare sectors. The roadshow served as part of Invest Qatar's ongoing efforts to deepen economic relations with the US and forge long-term partnerships.

During the roadshow, Invest Qatar engaged with prominent US companies and investors, highlighting Qatar's competitive business environment, advanced infrastructure, and innovation ecosystem. The delegation met with companies like Arbor Biotech, Alloy Therapeutics, Entech, and Enveda, all of which operate in the biotechnology and healthcare sectors. These companies are focused on areas such as gene-editing, AI-driven drug discovery, software integration, and automated laboratory technologies.

A notable event during the roadshow was a high-level roundtable hosted jointly with law firm DLA Piper. The discussion centered on Qatar's investment proposition and potential opportunities for international expansion, market entry, and strategic investment. The conversation covered key sectors like financial technology (Fintech), artificial intelligence (AI), health technology (Healthtech), and cybersecurity.

Chief Investment Development Officer at Invest Qatar, Fahad Al Kuwari, emphasized Qatar's commitment to building long-term relationships with investors and businesses. He noted that the country offers an attractive platform for companies looking to establish or expand operations, access regional opportunities, and benefit from advanced infrastructure, a strong research ecosystem, and a favorable business environment.

According to Invest Qatar's FDI Project Monitor, these initiatives have generated over 17,500 jobs and generated $26 billion in capital expenditure.